Reserpine differentially affects cocaine-induced behavior in low and high responders to novelty

Pharmacology Biochemistry and Behavior

Volumn 98, Issue 1, 2011, Pages 43-53

  Verheij, Michel M M ^a,b   Cools, Alexander R ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Behaviour; Cocaine pharmacology; Individual differences; Reserpine pharmacology; Storage pools; Storage vesicles

Indexed keywords

COCAINE; DOPAMINE; MONOAMINE; RESERPINE;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR CHANGE; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; DRUG SENSITIVITY; MALE; NONHUMAN; NUCLEUS ACCUMBENS; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; RAT; REARING;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; BEHAVIOR, ANIMAL; COCAINE; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXPLORATORY BEHAVIOR; MALE; NUCLEUS ACCUMBENS; RATS; RATS, WISTAR; RESERPINE;

RATTUS;

EID: 78650797328     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2010.11.021     Document Type: Article

References (62)

1. M. Amalric, and G.F. Koob Functionally selective neurochemical afferents and efferents of the mesocorticolimbic and nigrostriatal dopamine system Prog Brain Res 99 1993 209 226
2. S.A. Ball, K.M. Carroll, and B.J. Rounsaville Sensation seeking, substance abuse, and psychopathology in treatment-seeking and community cocaine abusers J Consult Clin Psychol 62 1994 1053 1057
3. S.J. Ballaz, H. Akil, and S.J. Watson Analysis of 5-HT6 and 5-HT7 receptor gene expression in rats showing differences in novelty-seeking behavior Neuroscience 147 2007 428 438
4. S.J. Ballaz, H. Akil, and S.J. Watson The 5-HT7 receptor: Role in novel object discrimination and relation to novelty-seeking behavior Neuroscience 149 2007 192 202
5. S.P. Berger, T.M. Winhusen, E.C. Somoza, J.M. Harrer, J.P. Mezinskis, and D.B. Leiderman A medication screening trial evaluation of reserpine, gabapentin and lamotrigine pharmacotherapy of cocaine dependence Addiction 100 Suppl. 1 2005 58 67
6. R.A. Bevins, J.E. Klebaur, and M.T. Bardo Individual differences in response to novelty, amphetamine-induced activity and drug discrimination in rats Behav Pharmacol 8 1997 113 123
7. E. Carboni, A. Imperato, L. Perezzani, and G. Di Chiara Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats Neuroscience 28 1989 653 661
8. V.I. Chefer, I. Zakharova, and T.S. Shippenberg Enhanced responsiveness to novelty and cocaine is associated with decreased basal dopamine uptake and release in the nucleus accumbens: quantitative microdialysis in rats under transient conditions J Neurosci 23 2003 3076 3084
9. T.L. Colliver, S.J. Pyott, M. Achalabun, and A.G. Ewing VMAT-Mediated changes in quantal size and vesicular volume J Neurosci 20 2000 5276 5282
10. A.R. Cools, and B.A. Ellenbroek Animal models of personality H.A. D'Haenen, J.A. den Boer, P. Willner, Biological psychiatry vol. 2 2002 John Wiley London 1333 1344
11. A.R. Cools, and M.A. Gingras Nijmegen high and low responders to novelty: a new tool in the search after the neurobiology of drug abuse liability Pharmacol Biochem Behav 60 1998 151 159
12. A.R. Cools, and T. Tuinstra Neurochemical evidence that mesolimbic noradrenaline directs mesolimbic dopamine, implying that noradrenaline, like dopamine, plays a key role in goal-directed and motivational behavior A.M. Graybiel, M.R. Delong, S.T. Kitai, The basal ganglia VI: advances in behavioral biology vol. 54 2003 Plenum Publishers New York 323 334
13. A.R. Cools, and M.M. Verheij Alpha-adrenoceptors, but not beta-adrenoceptors, regulate the extracellular release of dopamine stored in reserpine-sensitive vesicular pools in the nucleus accumbens Abstract viewer and itinerary planner. Society for neuroscience 32nd annual meeting 2002, Orlando, USA; Program no. 736.3.2002 2002
14. A.R. Cools, R. Brachten, D. Heeren, A. Willemen, and B. Ellenbroek Search after neurobiological profile of individual-specific features of Wistar rats Brain Res Bull 24 1990 49 69
15. A.R. Cools, B.A. Ellenbroek, M.A. Gingras, A. Engbersen, and D. Heeren Differences in vulnerability and susceptibility to dexamphetamine in Nijmegen high and low responders to novelty: a dose-effect analysis of spatio-temporal programming of behaviour Psychopharmacology Berl 132 1997 181 187
16. A. Dahlstrom, K. Fuxe, and N.A. Hillarp The site of action of reserpine Acta Pharmacol Toxicol Copenh 22 1965 277 292
17. M. Davis Cocaine: excitatory effects on sensorimotor reactivity measured with acoustic startle Psychopharmacol Berl 86 1985 31 36 (Pubitemid 15075569)
18. F. Dellu, P.V. Piazza, W. Mayo, M. Le Moal, and H. Simon Novelty-seeking in rats: biobehavioral characteristics and possible relationship with the sensation-seeking trait in man Neuropsychobiology 34 1996 136 145
19. G. Di Chiara, and A. Imperato Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats Proc Natl Acad Sci USA 85 1988 5274 5278
20. B.A. Ellenbroek, and A.R. Cools Stereotyped behaviour F. Van Haaren, Methods in behavioral pharmacology 1993 Elsevier St. Louis 519 538
21. B.A. Ellenbroek, and A.R. Cools Apomorphine susceptibility and animal models for psychopathology: genes and environment Behav Genet 32 2002 349 361
22. S.M. Florin, R. Kuczenski, and D.S. Segal Effects of reserpine on extracellular caudate dopamine and hippocampus norepinephrine responses to amphetamine and cocaine: mechanistic and behavioral considerations J Pharmacol Exp Ther 274 1995 231 241
23. L.W. Gong, I. Hafez, G. Alvarez-de-Toledo, and M. Lindau Secretory vesicles membrane area is regulated in tandem with quantal size in chromaffin cells J Neurosci 23 2003 7917 7921
24. D.A. Gorelick, E.L. Gardner, and Z.X. Xi Agents in development for the management of cocaine abuse Drugs 64 2004 1547 1573
25. L.M. Gynther, G. Carey, I.I. Gottesman, and G.P. Vogler A twin study of non-alcohol substance abuse Psychiatry Res 56 1995 213 220
26. J.P. Henry, C. Sagne, C. Bedet, and B. Gasnier The vesicular monoamine transporter: from chromaffin granule to brain Neurochem Int 32 1998 227 246
27. M.S. Hooks, G.H. Jones, A.D. Smith, D.B. Neill, and J.B. Justice Jr. Individual differences in locomotor activity and sensitization Pharmacol Biochem Behav 38 1991 467 470
28. M.S. Hooks, G.H. Jones, A.D. Smith, D.B. Neill, and J.B. Justice Jr. Response to novelty predicts the locomotor and nucleus accumbens dopamine response to cocaine Synapse 9 1991 121 128
29. M.S. Hooks, A.C. Colvin, J.L. Juncos, and J.B. Justice Jr. Individual differences in basal and cocaine-stimulated extracellular dopamine in the nucleus accumbens using quantitative microdialysis Brain Res 587 1992 306 312
30. Y.L. Hurd, and U. Ungerstedt Cocaine: an in vivo microdialysis evaluation of its acute action on dopamine transmission in rat striatum Synapse 3 1989 48 54
31. L.T. Jaffe, and R.P. Archer The prediction of drug use among college students from MMPI, MCMI, and sensation seeking scales J Pers Assess 51 1987 243 253
32. B. Johnels Reserpine-induced rigidity in rats: drug effects on muscle tone from corpus striatum and nucleus accumbens Pharmacol Biochem Behav 19 1983 463 470
33. B. Johnels, G. Steg, and U. Ungerstedt A method for mechanographical recording of muscle tone in the rat: the effect of some antiparkinsonian drugs on rigidity induced by reserpine Brain Res 140 1978 177 181
34. I. Jurna Striatal monoamines and reserpine and chlorpromazine rigidity Pharmacol Ther 2 1976 113 128
35. M. Kabbaj Neurobiological bases of individual differences in emotional and stress responsiveness: high responders-low responders model Arch Neurol 61 2004 1009 1012
36. N. Kirshner, M. Rorie, and D.L. Kamin Inhibition of dopamine uptake in vitro by reserpine administered in vivo J Pharmacol Exp Ther 141 1963 285 289
37. T.H. Lee, R. Balu, C. Davidson, and E.H. Ellinwood Differential time-course profiles of dopamine release and uptake changes induced by three dopamine uptake inhibitors Synapse 41 2001 301 310
38. M. Lyon, and T. Robbins The action of central nervous system stimulant drugs: a general theory concerning amphetamine effects W. Essmann, L. Valzelli, Current developments in psychopharmacology vol. 2 1975 Spectrum New York 79 163
39. J.R. Mantsch, A. Ho, S.D. Schlussman, and M.J. Kreek Predictable individual differences in the initiation of cocaine self-administration by rats under extended-access conditions are dose-dependent Psychopharmacol Berl 157 2001 31 39
40. B.A. McMillen CNS stimulants: two distinct mechanisms of action for amphetamine-like drugs Trends Pharmacol Sci 4 1983 429 432
41. B.A. McMillen, D.C. German, and P.A. Shore Functional and pharmacological significance of brain dopamine and norepinephrine storage pools Biochem Pharmacol 29 1980 3045 3050
42. P.V. Piazza, J.M. Deminiere, M. Le Moal, and H. Simon Factors that predict individual vulnerability to amphetamine self-administration Science 245 1989 1511 1513
43. P.V. Piazza, F. Rouge-Pont, J.M. Deminiere, M. Kharoubi, M. Le Moal, and H. Simon Dopaminergic activity is reduced in the prefrontal cortex and increased in the nucleus accumbens of rats predisposed to develop amphetamine self-administration Brain Res 567 1991 169 174
44. P.V. Piazza, V. Deroche-Gamonent, F. Rouge-Pont, and M. Le Moal Vertical shifts in self-administration dose-response functions predict a drug-vulnerable phenotype predisposed to addiction J Neurosci 20 2000 4226 4232
45. C. Pifl, H. Drobny, H. Reither, O. Hornykiewicz, and E.A. Singer Mechanism of the dopamine-releasing actions of amphetamine and cocaine: plasmalemmal dopamine transporter versus vesicular monoamine transporter Mol Pharmacol 47 1995 368 373
46. E.N. Pothos, V. Davila, and D. Sulzer Presynaptic recording of quanta from midbrain dopamine neurons and modulation of the quantal size J Neurosci 18 1998 4106 4118
47. F. Rouge-Pont, P.V. Piazza, M. Kharouby, M. Le Moal, and H. Simon Higher and longer stress-induced increase in dopamine concentrations in the nucleus accumbens of animals predisposed to amphetamine self-administration. A microdialysis study Brain Res 602 1993 169 174
48. T. Saigusa, T. Tuinstra, N. Koshikawa, and A.R. Cools High and low responders to novelty: effects of a catecholamine synthesis inhibitor on novelty-induced changes in behaviour and release of accumbal dopamine Neuroscience 88 1999 1153 1163
49. J. Scheel-Kruger, C. Braestrup, M. Nielson, K. Golembiowska, and E. Mogilnicka Cocaine: discussion on the role of dopamine in the biochemical mechanism of action E.H. Ellinwood Jr. M.M. Kilbey, Advances in behavioral biology 1977 Plenum New York 373 407
50. S. Southwick, and R.J. Anderson Antagonism of reserpine rigidity without inducing sedation Psychopharmacology 74 1981 29 32
51. M.B. Van den Bree, E.O. Johnson, M.C. Neale, and R.W. Pickens Genetic and environmental influences on drug use and abuse/dependence in male and female twins Drug Alcohol Depend 52 1998 231 241
52. B.J. Venton, A.T. Seipel, P.E. Phillips, W.C. Wetsel, D. Gitler, and P. Greengard Cocaine increases dopamine release by mobilization of a synapsin-dependent reserve pool J Neurosci 26 2006 3206 3209
53. M.M. Verheij, and A.R. Cools Differential contribution of storage pools to the extracellular amount of accumbal dopamine in high and low responders to novelty: effects of reserpine J Neurochem 100 2007 810 821
54. M.M. Verheij, and A.R. Cools Twenty years of dopamine research: Individual differences in the response of accumbal dopamine to environmental and pharmacological challenges Eur J Pharmacol 585 2008 228 244
55. M.M. Verheij, and A.R. Cools Accumbal noradrenaline that contributes to the alpha-adrenoceptor-mediated release of dopamine from reserpine-sensitive storage vesicles in the nucleus accumbens is derived from alpha-methyl-para- tyrosine-sensitive pools J Neural Transm 116 2009 389 394
56. M.M. Verheij, and A.R. Cools Mesolimbic alpha-, but not beta-adrenoceptors control the accumbal release of dopamine that is derived from reserpine-sensitive storage vesicles Neuroscience 162 2009 1163 1173
57. M.M. Verheij, J.V. Veenvliet, T. Groot Kormelink, M. Steenhof, and A.R. Cools Individual differences in the sensitivity to serotonergic drugs: a pharmacobehavioural approach using rats selected on the basis of their response to novelty Psychopharmacol Berl 205 2009 441 455
58. M.M. Verheij, R. Peters, L. Spiegelberg, E. de Mulder, and A.R. Cools In vivo rat approach to discover potential new anti-Parkinson agents such as SKF 83959 that lack unwanted side-effects in MPTP-lesioned Rhesus monkeys Ninth international basal ganglia society meeting 2007, Egmond aan Zee, The Netherlands; Program no. 110 2007
59. M.M. Verheij, E.L. De Mulder, E. De Leonibus, K.M. Van Loo, and A.R. Cools Rats that differentially respond to cocaine differ in their dopaminergic storage capacity of the nucleus accumbens J Neurochem 105 2008 2122 2133
60. J.A. Wagner Structure of catecholamine secretory vesicles from PC12 cells J Neurochem 45 1985 1244 1253
61. B.H. Wagner, and R.J. Anderson Prevention of reserpine rigidity by alpha-2 adrenergic antagonists Pharmacol Biochem Behav 16 1982 731 735
62. T. Winhusen, E. Somoza, O. Sarid-Segal, R.J. Goldsmith, J.M. Harrer, and F.S. Coleman A double-blind, placebo-controlled trial of reserpine for the treatment of cocaine dependence Drug Alcohol Depend 91 2007 205 212 (Pubitemid 47554602)